VIRAL PEPTIDES THAT INTERACT WITH HLA-A2 INHIBIT CYTO-TOXIC T-CELL ACTIVITY

VIRAL PEPTIDES THAT INTERACT WITH HLA-A2 INHIBIT CYTO-TOXIC T-CELL ACTIVITY

Detalles Bibliográficos
Autores principales:	Robbins, P, Mcmichael, A
Formato:	Journal article
Publicado:	1988

Ejemplares similares

Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
por: Bowness, P, et al.
Publicado: (1994)

Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice.
por: Savage, P, et al.
Publicado: (2002)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER
por: Peto, R
Publicado: (1985)

24TH FORUM IN IMMUNOLOGY - HIV-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T - DISCUSSION
por: Koup, R, et al.
Publicado: (1989)

HLA-peptide tetrameric complexes.
por: Ogg, G, et al.
Publicado: (1998)

Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
por: Robbins, P, et al.
Publicado: (1989)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY
por: Peto, R
Publicado: (1985)

Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
por: Bodmer, H, et al.
Publicado: (1989)

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.
por: Savage, P, et al.
Publicado: (2002)

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
por: Huet, S, et al.
Publicado: (1990)

CHARACTERIZATION OF BLAST CELLS BY ULTRASTRUCTURAL CYTO-CHEMISTRY AND MONOCLONAL-ANTIBODIES
por: Miguel, J, et al.
Publicado: (1983)

Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.
por: Stewart-Jones, G, et al.
Publicado: (2005)

A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
por: Moots, R, et al.
Publicado: (1991)

Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes.
por: Robbins, P, et al.
Publicado: (1991)

Dendrimers functionalized with membrane-interacting peptides for viral inhibition
por: Tarallo R, et al.
Publicado: (2013-02-01)

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27
por: Bowness, P, et al.
Publicado: (1995)

HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS
por: Bowness, P, et al.
Publicado: (1995)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
por: Kollnberger, S, et al.
Publicado: (2007)

INTERACTION BETWEEN INFLUENZA-VIRUS AND HLA ANTIGENS
por: Hildreth, J, et al.
Publicado: (1981)

Mutants of HLA-A2 in the analysis of its structure and function.
por: Strominger, J, et al.
Publicado: (1989)

HLA-KIR Interactions and Immunity to Viral Infections
por: Masoud Sabouri Ghannad, et al.
Publicado: (2014-02-01)

HLA restriction of human cytotoxic T cells.
por: Mcmichael, A
Publicado: (1980)

HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
por: Barouch, D, et al.
Publicado: (1995)

Evidence of widespread binding of HLA class I molecules to peptides.
por: Frelinger, J, et al.
Publicado: (1990)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
por: Matsui, M, et al.
Publicado: (1994)

Cyto-Neurology in Ischemia
por: Cláudio Roque, et al.
Publicado: (2022-07-01)

Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity
por: Himanshu Brahmbhatt, et al.
Publicado: (2022-01-01)

Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.
por: Tafuro, S, et al.
Publicado: (2001)

Specific surface area of titanium dioxide (TiO2) particles influences cyto- and photo-toxicity
por: Xiong, Sijing, et al.
Publicado: (2013)

Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
por: Mcmichael, A, et al.
Publicado: (1988)

In Vitro and In Vivo Inhibitory Activities of Selected Traditional Medicinal Plants against Toxin-Induced Cyto- and Entero- Toxicities in Cholera
por: Rajitha Charla, et al.
Publicado: (2022-09-01)

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay
por: Walters, LC, et al.
Publicado: (2020)

Discovery of HLA-E-presented epitopes: MHC-E/Peptide binding and t-cell recognition
por: Ruibal, P, et al.
Publicado: (2022)

HLA-E-presented peptides as novel targets for HIV-1 therapy
por: S. Brackenridge, et al.
Publicado: (2019-12-01)

Numerical study of the effects of hydrodynamic interactions among cells for microfluidic holographic cyto-tomography
por: Angela Vitolo, et al.
Publicado: (2024-03-01)

Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex.
por: Bowness, P, et al.
Publicado: (1998)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
por: Tussey, L, et al.
Publicado: (1994)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
por: Braud, V, et al.
Publicado: (1999)

Identification of a novel HLA-A2 subtype, HLA-A*0216.
por: Barouch, D, et al.
Publicado: (1995)

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
por: Goulder, P, et al.
Publicado: (1997)